GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of New Zealand: shortage, and what it actually costs here — 20 comments in the full submission. View in context.
510
c/glp1aus·submitted 1 months ago by u/jarno_adeyemi

New Zealand: shortage, and what it actually costs here

TGAbranch of 15 comments

New Zealand: shortage, and what it actually costs here. I have gone back and forth on this for months. Assumed the New Zealand position applied here. It does not, and someone corrected me politely with the actual source. Subsidy criteria and authority requirements are published. For eligibility questions those…

Read the full submission and all 20 comments →

This branch

15 comments, started 1 months ago
u/rafael_ostergaard82 points·1 months ago

Compounded supply arrangements have changed materially in recent years. Advice predating that change describes a situation that no longer applies.

replysharereportpermalink
u/blunt_coldbox_2024-19 points·1 months ago

Careful, personal importation provisions are narrow and specific and the general version circulating here is wrong.

replysharereportpermalink
u/cormac_pereira1 point·1 months ago

Careful, personal importation provisions are narrow and specific and the general version circulating here is wrong.

This is the distinction that makes the rest of the board legible.

replysharereportpermalink
u/honest_syringe331 point·1 months ago

Small fix — that is the New Zealand arrangement, and the question is about Australia.

replysharereportpermalink
u/viktor_laurent1 point·1 months ago

This. New Zealand has its own regulator and its own funding decisions and the answers genuinely differ.

replysharereportpermalink
u/aussie_pbs_watchAU1 point·1 months ago

PBS criteria are published and searchable

replysharereportpermalink
u/ismael_pires68 points·1 months ago

The national shortage database is a primary source with expected resolution dates attached. It is public, searchable, and consistently more accurate than reporting about it.

replysharereportpermalink
u/lipid_panel_larrybloodwork16 points·1 months ago

say which state only if it matters, but always say which country

replysharereportpermalink
u/britta_nakamura5 points·1 months ago

Pharmacy-level availability and national supply are different questions: a pharmacy can be out while the wholesaler is not, and the pharmacist can check in minutes.

replysharereportpermalink
u/britta_boateng103 points·1 months ago

the shortage listing has an expected resolution date on it

replysharereportpermalink
u/arne_amankwah70 points·1 months ago

Push back: the compounded arrangements changed and the advice you are quoting predates the change.

replysharereportpermalink
u/lipid_panel_larrybloodwork106 points·1 months ago

do not import US advice into an Australian thread

replysharereportpermalink
u/tomas_lokken28 points·1 months ago

keep the script and the receipt for private health claims

replysharereportpermalink
u/jarno_adeyemiOP37 points·1 months ago

the price you pay depends on the listing status of your indication

replysharereportpermalink
u/rosa_sandvik8 points·1 months ago

Australia and New Zealand are separate systems and get conflated weekly

replysharereportpermalink

← back to the whole thread

About c/glp1aus

Australia and New Zealand: PBS listing status and what it does to out-of-pocket cost, TGA shortage notices, the 2024 compounding rule change that closed a major access route overnight, and NZ's unfunded-means-full-price reality.

20kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/glp1aus rules
  1. PBS/TGA claims need the notice or the schedule entry.
  2. AU and NZ are different systems. Say which.
  3. No naming compounders operating against the current rules.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.